Related Experiment Video
Updated: Sep 4, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics
Jingxia Du1, Hongchao Li2, Jingjing Song1
1Pharmacy Department, School of Basic Medical Sciences, Henan University of Science and Technology, Luoyang, China.
Abstract:
Mitochondrial dysfunction is a salient feature of myocardial ischemia/reperfusion injury (MIRI), while the potential mechanism of mitochondrial dynamics disorder remains unclear. This study sought to explore whether activation of Adenosine monophosphate-activated protein kinase (AMPK) could alleviate MIRI by regulating GTPase dynamin-related protein 1 (Drp1)-mediated mitochondrial dynamics. Isolated mouse hearts in a Langendorff perfusion system were subjected to ischemia/reperfusion (I/R) treatment, and H9C2 cells were subjected to hypoxia /reoxygenation (H/R) treatment in vitro. The results showed that AICAR, the AMPK activator, could significantly improve the function of left ventricular, decrease arrhythmia incidence and myocardial infarction area of isolated hearts. Meanwhile, AICAR increased superoxide dismutase (SOD) activity and decreased malondialdehyde (MDA) content in myocardial homogenate. Mechanistically, AICAR inhibited the phosphorylation of Drp1 at Ser 616 while enhanced phosphorylation of Drp1 at Ser 637. In addition, AICAR reduced the expression of inflammatory cytokines including TNF-ɑ, IL-6, and IL-1β, as well as mitochondrial fission genes Mff and Fis1, while improved the expression of mitochondrial fusion genes Mfn1 and Mfn2. Similar results were also observed in H9C2 cells. AICAR improved mitochondrial membrane potential (MMP), reduced reactive oxygen species (ROS) production, and inhibited mitochondrial damage. To further prove if Drp1 regulated mitochondrial dynamics mediated AMPK protection effect, the mitochondrial fission inhibitor Mdivi-1 was utilized. We found that Mdivi-1 significantly improved MMP, inhibited ROS production, reduced the expression of TNF-a, IL-6, IL-1β, Fis1, and Mff, and improved the expression of Mfn1 and Mfn2. However, the protection effect of Mdivi-1 was not reversed by AMPK inhibitor Compound C. In conclusion, this study confirmed that activation of AMPK exerted the protective effects on MIRI, which were largely dependent on the inhibition of Drp1-mediated mitochondrial fission.
Insights
Activation of Adenosine monophosphate-activated protein kinase (AMPK) protects against myocardial ischemia/reperfusion injury (MIRI) by inhibiting mitochondrial fission. This involves regulating GTPase dynamin-related protein 1 (Drp1)-mediated mitochondrial dynamics, reducing inflammation, and improving cardiac function.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Cellular Signaling
Background:
- Mitochondrial dysfunction is a key factor in myocardial ischemia/reperfusion injury (MIRI).
- The precise mechanisms of mitochondrial dynamics disruption in MIRI are not fully understood.
- Adenosine monophosphate-activated protein kinase (AMPK) is a potential therapeutic target for MIRI.
Purpose of the Study:
- To investigate if AMPK activation alleviates MIRI by modulating Drp1-mediated mitochondrial dynamics.
- To elucidate the role of Drp1 in AMPK-induced protection against MIRI.
Main Methods:
- Isolated mouse hearts and H9C2 cells were subjected to ischemia/reperfusion (I/R) or hypoxia/reoxygenation (H/R) injury.
- Treatment with AICAR (AMPK activator) and Mdivi-1 (Drp1 inhibitor) was employed.
- Measurements included cardiac function, infarct size, oxidative stress markers, inflammatory cytokines, and mitochondrial dynamics gene expression.
Main Results:
- AICAR treatment improved cardiac function, reduced infarct size, and decreased arrhythmia incidence in MIRI models.
- AICAR inhibited Drp1 phosphorylation at Ser 616, reduced fission gene expression, and decreased inflammatory cytokines.
- Mdivi-1 mimicked AICAR's protective effects, suggesting Drp1 inhibition is crucial for AMPK-mediated cardioprotection.
Conclusions:
- AMPK activation confers significant protection against MIRI.
- This protection is mediated through the inhibition of Drp1-dependent mitochondrial fission.
- Targeting AMPK and Drp1 represents a promising therapeutic strategy for MIRI.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
MAPK Signaling Cascades

